Showing 61 - 80 results of 926 for search '"Lung cancer"', query time: 0.08s Refine Results
  1. 61

    Integrating robotic surgery and pharmacotherapy: A dual approach to lung cancer management by Gnanendra Sai Kumar Nareboina, Prudhvi Raj Chalapaka

    Published 2024-01-01
    “…This innovative approach helps to improve the lung cancer treatment by setting a new standard for patient outcomes.…”
    Get full text
    Article
  2. 62

    CIMAvax-EGF®, new therapeutic alternative for lung cancer: its application in Cienfuegos by Yoana Herrera Leiva, Teresita Sabatés Llerandi

    Published 2017-04-01
    “…The overall objective of the study is to evaluate the safety and efficacy of the CIMAVAX-EGF therapeutic vaccine for the treatment of patients diagnosed with lung cancer in advanced stages of the disease and, within its specific objectives, to assess overall survival and the treated patients’ life quality.…”
    Get full text
    Article
  3. 63

    Postoperative Acute Exacerbation of IPF after Lung Resection for Primary Lung Cancer by Atsushi Watanabe, Nobuyoshi Kawaharada, Tetsuya Higami

    Published 2011-01-01
    “…The condition sometimes occurs in patients who underwent lung resection for primary lung cancer in the acute and subacute postoperative phases. …”
    Get full text
    Article
  4. 64
  5. 65
  6. 66
  7. 67
  8. 68
  9. 69
  10. 70
  11. 71
  12. 72
  13. 73

    Functional-proteomics-based investigation of the cellular response to farnesyltransferase inhibition in lung cancer by Yanbo Pan, Olena Berkovska, Soumitra Marathe, Georgios Mermelekas, Greta Gudoityte, Amare D. Wolide, Taner Arslan, Brinton Seashore-Ludlow, Janne Lehtiö, Lukas M. Orre

    Published 2025-02-01
    “…In this study, we performed a global proteomics analysis to investigate farnesylation and the effects of tipifarnib in lung cancer cell lines. Using metabolic labeling and mass spectrometry, we identified farnesylated proteins and mapped their subcellular localization. …”
    Get full text
    Article
  14. 74
  15. 75
  16. 76
  17. 77

    The Underlying Mechanism Involved in Gefitinib Resistance and Corresponding Experiment Validation in Lung Cancer by Puwei Song, Jianghui Zhou, Kaiqin Wu, Wenli Wang, Shaorui Gu

    Published 2023-01-01
    “…Gefitinib resistance remains a major problem in the treatment of lung cancer. However, the underlying mechanisms involved in gefitinib resistance are largely unclear. …”
    Get full text
    Article
  18. 78

    Dysregulation of NK and CD8+T Cells by the Microbiota Promotes the Progression of Lung Cancer by Shouxin Hu, Yanfang Zha, Wenwen Yang, Kele Cui, Min Cheng

    Published 2022-01-01
    “…The precise mechanisms by which microbiota regulate immune cells during the progression of lung cancer remain obscure. In this study, using a Kras-mutated-driven spontaneous lung cancer mouse model, we found that the depletion of microbiota can alleviate lung lesions in Kras-mutated mice at different stages of tumour development. …”
    Get full text
    Article
  19. 79
  20. 80